Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BMS-247550 (Ixabepilone) in Hormone Refractory Prostate Cancer
NCT00016393Phase 2Completed
- Sponsor
- SWOG Cancer Research Network
- Start
- Jun 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ixabepilone in prostate cancer (PCa), sponsored by SWOG Cancer Research Network. Primary endpoint: Prostate-Specific Antigen Response. Started Jun 2001; status: completed.
02
Drugs
ixabepilone
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00016393.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00016393.